Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Salt Sensitivity, Cardiovascular and Metabolic Disease

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
Indiana University
ClinicalTrials.gov Identifier:
NCT00005489
First received: May 25, 2000
Last updated: December 28, 2015
Last verified: December 2015
  Purpose
To identify the role of salt-sensitivity of blood pressure in the pathogenesis of hypertension.

Condition
Cardiovascular Diseases
Heart Diseases
Hypertension
Angina Pectoris
Cerebrovascular Accident
Myocardial Infarction
Diabetes Mellitus
Heart Failure, Congestive
Heart Failure

Study Type: Observational

Further study details as provided by Indiana University:

Study Start Date: January 1998
Estimated Study Completion Date: December 2001
Detailed Description:

DESIGN NARRATIVE:

Approximately 498 of 750 normal and hypertensive subjects who were carefully characterized in terms of blood pressure response to salt loading and depletion in the late 1970s were re-examined to identify physiological factors contributing to salt-sensitivity of blood pressure. This helped to confirm preliminary observations suggesting that salt sensitivity in normotensive subjects predicted the subsequent development of hypertension with aging. In addition, longitudinal observations in hypertensive patients and in normotensives helped to determine whether salt-sensitivity or salt-resistance of blood pressure were associated with differences in the risk for development of specific forms of cardiovascular disease (stroke, angina, myocardial infarction, congestive heart failure), renal and metabolic (diabetes mellitus) disorders.

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005489

Sponsors and Collaborators
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Myron Weinberger Indiana University-Purdue University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00005489     History of Changes
Other Study ID Numbers: 5005  R01HL057826 
Study First Received: May 25, 2000
Last Updated: December 28, 2015
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Heart Failure
Infarction
Cardiovascular Diseases
Heart Diseases
Myocardial Infarction
Stroke
Angina Pectoris
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Vascular Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Chest Pain
Pain
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on December 09, 2016